Poxel Announces Extended Cash Runway with Debt Restructuring Agreement

8 août 2022

Poxel extended its cash runway to at least February 2023 through debt restructuring and a new €6 million equity-linked financing with IRIS.

Lyon, France August 8, 2022 – Poxel extended its cash runway to at least February 2023 by restructuring its debt and securing a new €6 million equity-linked financing with IRIS. This added flexibility supports upcoming clinical milestones, including Phase 2 NASH results and the planned launch of rare-disease trials.

Download Poxel press release